Deng Z, Yan H, Lambotte O, Moog C, Su B
Front Immunol. 2025; 16:1540932.
PMID: 40070826
PMC: 11893560.
DOI: 10.3389/fimmu.2025.1540932.
Li B, Dong B, Xie L, Li Y
Int J Gen Med. 2025; 18:529-565.
PMID: 39911299
PMC: 11796455.
DOI: 10.2147/IJGM.S493021.
Yao X, Wu J, Yuan S, Yuan F
Int J Mol Med. 2025; 55(3).
PMID: 39886977
PMC: 11781520.
DOI: 10.3892/ijmm.2025.5494.
Bekaddour N, Smith N, Caspar B, Grinberg S, Giorgiutti S, Rodeschini V
Front Immunol. 2024; 15:1490593.
PMID: 39737176
PMC: 11682962.
DOI: 10.3389/fimmu.2024.1490593.
Liu D, Mai D, Jahn A, Murray T, Aitchison J, Gern B
bioRxiv. 2024; .
PMID: 39605723
PMC: 11601580.
DOI: 10.1101/2024.10.04.616580.
Human CD34-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy.
Fiore G, Weckwarth W, Paetzold K, Alberti Servera L, Gies M, Rosenhauer J
Front Immunol. 2024; 15:1433119.
PMID: 39575246
PMC: 11578708.
DOI: 10.3389/fimmu.2024.1433119.
Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines.
Rothen D, Dutta S, Krenger P, Pardini A, Vogt A, Josi R
Vaccines (Basel). 2024; 12(9).
PMID: 39340083
PMC: 11435730.
DOI: 10.3390/vaccines12091053.
Redefining our vision: an updated guide to the ocular immune system.
Wu M, Fletcher E, Chinnery H, Downie L, Mueller S
Nat Rev Immunol. 2024; 24(12):896-911.
PMID: 39215057
DOI: 10.1038/s41577-024-01064-y.
Classical dendritic cells contribute to hypoxia-induced pulmonary hypertension.
Mickael C, Sanders L, Lee M, Kumar R, Fonseca-Balladares D, Gandjeva A
FASEB J. 2024; 38(16):e70015.
PMID: 39212294
PMC: 11462638.
DOI: 10.1096/fj.202400338RR.
Crucial role of dendritic cells in the generation of anti-tumor T-cell responses and immunogenic tumor microenvironment to suppress tumor development.
Tominaga M, Uto T, Fukaya T, Mitoma S, Riethmacher D, Umekita K
Front Immunol. 2024; 15:1200461.
PMID: 39206204
PMC: 11349553.
DOI: 10.3389/fimmu.2024.1200461.
Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy.
Lecoultre M, Walker P, El Helali A
Clin Exp Med. 2024; 24(1):202.
PMID: 39196415
PMC: 11358230.
DOI: 10.1007/s10238-024-01443-8.
Building a human lung from pluripotent stem cells to model respiratory viral infections.
Turner D, Amoozadeh S, Baric H, Stanley E, Werder R
Respir Res. 2024; 25(1):277.
PMID: 39010108
PMC: 11251358.
DOI: 10.1186/s12931-024-02912-0.
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity.
Mahr A, Bennett-Boehm M, Rothemejer F, Weber I, Regan A, Franzen J
Sci Rep. 2024; 14(1):14595.
PMID: 38918496
PMC: 11199698.
DOI: 10.1038/s41598-024-65576-2.
Molluscum Contagiosum Virus: Biology and Immune Response.
Santacroce L, Magrone T
Adv Exp Med Biol. 2024; 1451:151-170.
PMID: 38801577
DOI: 10.1007/978-3-031-57165-7_10.
Inhibition Effects and Mechanisms of Marine Compound Mycophenolic Acid Methyl Ester against Influenza A Virus.
Wang Z, Sun L, Zhao H, Sow M, Zhang Y, Wang W
Mar Drugs. 2024; 22(5).
PMID: 38786581
PMC: 11122424.
DOI: 10.3390/md22050190.
Dysfunctional neutrophil type 1 interferon responses in preschool children with recurrent wheezing and IL-4-mediated aeroallergen sensitization.
Fitzpatrick A, Huang M, Mohammad A, Stephenson S, Kamaleswaran R, Grunwell J
J Allergy Clin Immunol Glob. 2024; 3(2):100229.
PMID: 38510797
PMC: 10950716.
DOI: 10.1016/j.jacig.2024.100229.
Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas.
Su C, Kim S, Wang C, Kirsch D, Monjazeb A
Semin Radiat Oncol. 2024; 34(2):243-257.
PMID: 38508788
PMC: 11216412.
DOI: 10.1016/j.semradonc.2024.01.001.
Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer.
Tiberio L, Laffranchi M, Zucchi G, Salvi V, Schioppa T, Sozzani S
Front Immunol. 2024; 15:1360291.
PMID: 38504978
PMC: 10948453.
DOI: 10.3389/fimmu.2024.1360291.
Dendritic Cells in Cancer Immunology and Immunotherapy.
Hato L, Vizcay A, Eguren I, Perez-Gracia J, Rodriguez J, Gallego Perez-Larraya J
Cancers (Basel). 2024; 16(5).
PMID: 38473341
PMC: 10930494.
DOI: 10.3390/cancers16050981.
CD4 T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors.
Lei X, de Groot D, Welters M, de Wit T, Schrama E, van Eenennaam H
Cell Mol Immunol. 2024; 21(4):374-392.
PMID: 38383773
PMC: 10978876.
DOI: 10.1038/s41423-024-01133-1.